Tidalsense raised $19 million to scale N-Tidal Diagnose, an AI-based platform designed to identify chronic obstructive pulmonary disease in about five minutes. The company is positioning the product as a faster diagnostic route that could improve triage and access compared with conventional pathways, while using AI to interpret inputs that support clinical decision-making at the point of care.